Literature DB >> 34006312

The prevalence of the iutA and ibeA genes in Escherichia coli isolates from severe and non-severe patients with bacteremic acute biliary tract infection is significantly different.

Mahoko Ikeda1,2, Tatsuya Kobayashi3, Fumie Fujimoto4, Yuta Okada3, Yoshimi Higurashi4, Keita Tatsuno3, Shu Okugawa3, Kyoji Moriya4,3.   

Abstract

BACKGROUND: Although Escherichia coli is the most frequently isolated microorganism in acute biliary tract infections with bacteremia, data regarding its virulence are limited.
RESULTS: Information on cases of bacteremia in acute biliary tract infection in a retrospective study was collected from 2013 to 2015 at a tertiary care hospital in Japan. Factors related to the severity of infection were investigated, including patient background, phylogenetic typing, and virulence factors of E. coli, such as adhesion, invasion, toxins, and iron acquisition. In total, 72 E. coli strains were identified in 71 cases, most of which primarily belonged to the B2 phylogroup (68.1%). The presence of the iutA gene (77.3% in the non-severe group, 46.4% in the severe group, P = 0.011) and the ibeA gene (9.1% in the non-severe group, and 35.7% in the severe group, P = 0.012) was significantly associated with the severity of infection. Among the patient characteristics, diabetes mellitus with organ involvement and alkaline phosphatase were different in the severe and non-severe groups.
CONCLUSIONS: We showed that bacteremic E. coli strains from acute biliary tract infections belonged to the virulent (B2) phylogroup. The prevalence of the iutA and ibeA genes between the two groups of bacteremia severity was significantly different.

Entities:  

Keywords:  Bacteremia; Biliary tract infection; Extraintestinal pathogenic Escherichia coli; Severity; Virulence factors; ibeA; iutA

Year:  2021        PMID: 34006312     DOI: 10.1186/s13099-021-00429-1

Source DB:  PubMed          Journal:  Gut Pathog        ISSN: 1757-4749            Impact factor:   4.181


  49 in total

1.  The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.

Authors:  Ming-Cheng Wang; Chin-Chung Tseng; Chiung-Yu Chen; Jiunn-Jong Wu; Jeng-Jong Huang
Journal:  Clin Infect Dis       Date:  2002-10-28       Impact factor: 9.079

Review 2.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

Review 3.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

Review 4.  E. coli as an all-rounder: the thin line between commensalism and pathogenicity.

Authors:  Andreas Leimbach; Jörg Hacker; Ulrich Dobrindt
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

5.  Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.

Authors:  Rungsun Rerknimitr; Evan L Fogel; Cem Kalayci; Edward Esber; Glen A Lehman; Stuart Sherman
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

6.  Spectrum of pathogens in acute cholangitis in patients with and without biliary endoprosthesis.

Authors:  Andreas Weber; Jochen Schneider; Stefan Wagenpfeil; Philipp Winkle; Julia Riedel; Nina Wantia; Susanne Feihl; Franziska Römmler; Dorothee M Baur; Roland M Schmid; Hana Algül; Wolfgang Huber
Journal:  J Infect       Date:  2013-04-17       Impact factor: 6.072

Review 7.  Diagnosis and management of acute cholangitis.

Authors:  John G Lee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

Review 8.  Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports.

Authors:  Jolanta Sarowska; Bozena Futoma-Koloch; Agnieszka Jama-Kmiecik; Magdalena Frej-Madrzak; Marta Ksiazczyk; Gabriela Bugla-Ploskonska; Irena Choroszy-Krol
Journal:  Gut Pathog       Date:  2019-02-21       Impact factor: 4.181

9.  Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis.

Authors:  Tassilo Kruis; Sarah Güse-Jaschuck; Britta Siegmund; Thomas Adam; Hans-Jörg Epple
Journal:  BMC Gastroenterol       Date:  2020-03-12       Impact factor: 3.067

10.  Clinical and microbiological characteristics of patients with biliary disease.

Authors:  Xue-Xiang Gu; Meng-Pei Zhang; Yan-Feng Zhao; Guang-Ming Huang
Journal:  World J Gastroenterol       Date:  2020-04-14       Impact factor: 5.742

View more
  2 in total

1.  Extraintestinal Pathogenic Escherichia coli Utilizes Surface-Located Elongation Factor G to Acquire Iron from Holo-Transferrin.

Authors:  Yu Sun; Xuhang Wang; Qianwen Gong; Jin Li; Haosheng Huang; Feng Xue; Jianjun Dai; Fang Tang
Journal:  Microbiol Spectr       Date:  2022-03-07

2.  Recurrent bacteremia with a hypermucoviscous Escherichia coli isolated from a patient with perihilar cholangiocarcinoma: insights from a comprehensive genome-based analysis.

Authors:  Bernd Neumann; Norman Lippmann; Sebastian Wendt; Thomas Karlas; Christoph Lübbert; Guido Werner; Yvonne Pfeifer; Christopher F Schuster
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-06-24       Impact factor: 6.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.